191 related articles for article (PubMed ID: 24740523)
1. SCAI expert consensus statement for aorto-iliac arterial intervention appropriate use.
Klein AJ; Feldman DN; Aronow HD; Gray BH; Gupta K; Gigliotti OS; Jaff MR; Bersin RM; White CJ;
Catheter Cardiovasc Interv; 2014 Oct; 84(4):520-8. PubMed ID: 24740523
[TBL] [Abstract][Full Text] [Related]
2. SCAI expert consensus statement for infrapopliteal arterial intervention appropriate use.
Gray BH; Diaz-Sandoval LJ; Dieter RS; Jaff MR; White CJ;
Catheter Cardiovasc Interv; 2014 Oct; 84(4):539-45. PubMed ID: 25045160
[TBL] [Abstract][Full Text] [Related]
3. SCAI expert consensus statement for femoral-popliteal arterial intervention appropriate use.
Klein AJ; Pinto DS; Gray BH; Jaff MR; White CJ; Drachman DE;
Catheter Cardiovasc Interv; 2014 Oct; 84(4):529-38. PubMed ID: 24753020
[TBL] [Abstract][Full Text] [Related]
4. SCAI guidelines on device selection in Aorto-Iliac arterial interventions.
Feldman DN; Armstrong EJ; Aronow HD; Banerjee S; Díaz-Sandoval LJ; Jaff MR; Jayasuriya S; Khan SU; Klein AJ; Parikh SA; Rosenfield K; Shishehbor MH; Swaminathan RV; White CJ
Catheter Cardiovasc Interv; 2020 Oct; 96(4):915-929. PubMed ID: 32406565
[No Abstract] [Full Text] [Related]
5. Aorto-iliac peripheral artery disease.
Javed IN; Hawkins BM
Prog Cardiovasc Dis; 2021; 65():9-14. PubMed ID: 33631164
[TBL] [Abstract][Full Text] [Related]
6. Treatment of the aorto-iliac segment in complex lower extremity arterial occlusive disease.
Wressnegger A; Kinstner C; Funovics M
J Cardiovasc Surg (Torino); 2015 Feb; 56(1):73-9. PubMed ID: 25475917
[TBL] [Abstract][Full Text] [Related]
7. Mid-term results of endovascular reconstruction for aorto-iliac obstructive disease.
Piffaretti G; Tozzi M; Lomazzi C; Rivolta N; Laganà D; Carrafiello G; Caronno R; Castelli P
Int Angiol; 2007 Mar; 26(1):18-25. PubMed ID: 17353884
[TBL] [Abstract][Full Text] [Related]
8. Focal aorto-iliac atherosclerosis amenable to endovascular interventions though considered benign carry a significant risk of cardiovascular mortality: clinical investigation.
Ioannou C; Kostas T; Kontopodis N; Manousaki E; Chlouverakis G; Kehagias E; Tsetis D
Int Angiol; 2015 Feb; 34(1):67-74. PubMed ID: 24824841
[TBL] [Abstract][Full Text] [Related]
9. Subintimal angioplasty of chronic total occlusion in iliac arteries: a safe and durable option.
Chen BL; Holt HR; Day JD; Stout CL; Stokes GK; Panneton JM
J Vasc Surg; 2011 Feb; 53(2):367-73. PubMed ID: 21030201
[TBL] [Abstract][Full Text] [Related]
10. Intravenous intravascular ultrasound using the AcuNav ultrasound catheter for guiding recanalization of aortoiliac chronic total occlusions.
Hishikari K; Hikita H; Sugiyama T; Oumi T; Kimura S; Takahashi A; Isobe M
J Endovasc Ther; 2015 Apr; 22(2):269-71. PubMed ID: 25809374
[No Abstract] [Full Text] [Related]
11. The Antegrade Approach Using Transbrachial Access Improves Technical Success Rate of Endovascular Recanalization of TASC C-D Aortoiliac Occlusion in Case of Failed Femoral Access.
Millon A; Della Schiava N; Brizzi V; Arsicot M; Boudjelit T; Herail J; Feugier P; Lermusiaux P
Ann Vasc Surg; 2015 Oct; 29(7):1346-52. PubMed ID: 26122414
[TBL] [Abstract][Full Text] [Related]
12. Trans-Atlantic Inter-Society Consensus II C and D iliac lesions can be treated by endovascular and hybrid approach: a single-center experience.
Taurino M; Persiani F; Fantozzi C; Ficarelli R; Rizzo L; Stella N
Vasc Endovascular Surg; 2014 Feb; 48(2):123-8. PubMed ID: 24270686
[TBL] [Abstract][Full Text] [Related]
13. Endovascular treatment of external iliac artery occlusive disease: midterm results.
Revuelta Suero S; Martínez López I; Hernando Rydings M; Marqués de Marino P; Saiz Jerez A; Hernández Mateo MM; Serrano Hernando FJ
J Endovasc Ther; 2014 Apr; 21(2):223-9. PubMed ID: 24754281
[TBL] [Abstract][Full Text] [Related]
14. Primary stenting is nowadays the gold standard treatment for TASC II A & B iliac lesions: the definitive MISAGO 1-year results.
Deloose K; Bosiers M; Callaert J; Verbist J; Vermassen F; Scheinert D; Torsello G; Peeters P
J Cardiovasc Surg (Torino); 2017 Jun; 58(3):416-421. PubMed ID: 25331010
[TBL] [Abstract][Full Text] [Related]
15. Endovascular revascularization for aortoiliac atherosclerotic disease.
Aggarwal V; Waldo SW; Armstrong EJ
Vasc Health Risk Manag; 2016; 12():117-27. PubMed ID: 27099509
[TBL] [Abstract][Full Text] [Related]
16. Shared and differential factors influencing restenosis following endovascular therapy between TASC (Trans-Atlantic Inter-Society Consensus) II class A to C and D lesions in the femoropopliteal artery.
Iida O; Takahara M; Soga Y; Suzuki K; Hirano K; Kawasaki D; Shintani Y; Suematsu N; Yamaoka T; Nanto S; Uematsu M
JACC Cardiovasc Interv; 2014 Jul; 7(7):792-8. PubMed ID: 25060024
[TBL] [Abstract][Full Text] [Related]
17. Outcomes of endovascular treatment for TASC C and D aorto-iliac lesions.
Ahn S; Park KM; Kim YK; Kim JI; Moon IS; Hong KC; Jeon YS; Kim JY
Asian J Surg; 2017 May; 40(3):215-220. PubMed ID: 26787498
[TBL] [Abstract][Full Text] [Related]
18. Intervention of Prohibitive Aortic and Iliac Atherosclerotic Stenosis to Allow Successful Transfemoral Transcatheter Aortic Valve Replacement.
Sanghvi K; Singh M
JACC Cardiovasc Interv; 2018 Sep; 11(17):e137-e140. PubMed ID: 30121283
[No Abstract] [Full Text] [Related]
19. An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).
; Jaff MR; White CJ; Hiatt WR; Fowkes GR; Dormandy J; Razavi M; Reekers J; Norgren L
J Endovasc Ther; 2015 Oct; 22(5):663-77. PubMed ID: 26239796
[TBL] [Abstract][Full Text] [Related]
20. Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions.
Ye W; Liu CW; Ricco JB; Mani K; Zeng R; Jiang J
J Vasc Surg; 2011 Jun; 53(6):1728-37. PubMed ID: 21609804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
